Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure

British Journal of Cancer

Volumn 67, Issue 5, 1993, Pages 975-980

  Li, C J ^a   Miyamoto, Y ^a   Kojima, Y ^a   Maeda, H ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BOVINE SERUM ALBUMIN; CARBOHYDRATE DERIVATIVE; CHROMIUM 51; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; DIARRHEA; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; DRUG TISSUE LEVEL; FEMALE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; LETHAL DOSE; LEUKOPENIA; MACROMOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; WALKER CARCINOMA; WEIGHT REDUCTION;

ANGIOTENSIN II; ANIMAL; BLOOD PRESSURE; BONE MARROW; CAPILLARY PERMEABILITY; CARCINOMA 256, WALKER; FEMALE; HYPERTENSION; MALEIC ANHYDRIDES; METHYLGLUCOSIDES; POLYSTYRENES; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION; ZINOSTATIN;

EID: 0027299899     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1993.179     Document Type: Article

References (39)

1. COPE, D.A., DEWHIRST, M.W., FRIEDMAN, H.S., BIGNER, D.D. & ZALUTSKY, M.R. (1990). Enhanced delivery of a monoclonal antibody F(ab)2 fragment to subcutaneous human glioma xenografts using local hyperthermia. Cancer Res., 50, 1803-1809.
2. COURTICE, F.C. (1963). The orgin of lipoprotein in lymph. In Lymph and Lymphatic System, Meyersen, H.S. (Chairman) pp. 89-126. Springfield, Charles C. Thomas: Illinois.
3. DVORAK, H.F., SENGER, D R., DVORAK, A.M., HARVER, VS. & McDONAGH, J. (1985). Regulation of extravascular coagulation by microvascular permeability. Science, 227, 1059-1061.
4. FOLKMAN, J. & KLAGSBRUN, M. (1987). Angiogenic factors. Science, 235, 442-447.
5. HNATOWICH, D.J., LAYNE, W.W. & CHILDS, R.L. (1982). The preparation and labeling of DTPA-coupled albumin. Int. J. Appl. Radiat. Isot., 33, 327-332.
6. HORI, K., SUZUKI, M., ABE, I., SAITO, S. & SATO, H. (1983). Microocclusion technique for measurement of the microvascular pressure in tumor and subcutis. Jpn. J. Cancer Res., 74, 122-127.
7. HORI, K., SUZUKI, M., ABE, I., SAITO, S. & SATO, H. (1984). Increase in tumor vascular area due to increased blood flow by angiotensin II in rats. J. Natl Cancer Inst., 74, 453-459.
8. HORI, K., SUZUKI, M., TANDA, S., SAITO, S., SHINOZAKI, S. & ZHANG, Q.-H. (1991). Fluctuation in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension. Jpn. J. Cancer Res., 82, 1309-1316.
9. IWAI, K., MAEDA, H. & KONNO, T. (1984). Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res., 44, 2115-2121.
10. IWAI, K., MAEDA, H., KONNO, T., MATSUMURA, Y., YAMASHITA, R., YAMASAKI, K., HIRAYAMA, S. & MIYAUCHI, Y. (1987). Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver. Anticancer Res., 7, 321-328.
11. JAIN, R.K. (1990). Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res. (Suppl.), 50, 814s–819s.
12. KALOFONOS, H., ROWLINSON, G. & EPENETOS, A.A. (1990). Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation. Cancer Res., 50, 159–163.
13. KHAW, B.A., FALLON, J.T., STRAUSS, H.W. & HARBER, F. (1980). Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid. Science, 209, 295-297.
14. KOBAYASHI, A., ODA, T. & MAEDA, H. (1988). Protein binding of macromolecular anticancer agent SMANCS: characterization of poly(styrene-co-maleic acid) derivatives as an albumin binding ligand. J. Bioactive Compatible Polym., 3, 319-333.
15. KONNO, T., MAEDA, H., IWAI, K., TASHIRO, S., MAKI, S., MOCHINAGA, M., HIRAOKA, T. & YOKOYAMA, I. (1984a). Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur. J. Cancer Clin. Oncol., 19, 1053-1065.
16. KONNO, T., MAEDA, H., IWAI, K., MAKI, S., TASHIRO, S., UCHIDA, M. & MIYAUCHI, Y. (1984b). Selective targeting of anticancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium. Cancer, 54, 2367-2374.
17. KUROIWA, T., AOKI, K., TANIGUCHI, S., HASUDA, K. & BABA, T. (1987). Efficacy of two-route chemotherapy using cis-diammine-dichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor. Cancer Res., 47, 3618-3623.
18. MAEDA, H., TAKESHITA, J. & KANAMARU, R. (1979a). A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic. Int. J. Pept. Protein Res., 14, 81-87.
19. MAEDA, H., TAKESHITA, J., KANAMARU, R., SATO, H., KHATOH, J. & SATO, H. (1979b). Antimetastatic and antitumor activity of a derivative of neocarzinostatin: an organic solvent-and water-soluble polymer-conjugated protein. Gann (Jpn. J. Cancer Res.), 70, 601-606.
20. MAEDA, H., MATSUMOTO, T., KONNO, T., IWAI, K. & UEDA, M. (1984). Tailor-making of protein drugs by polymer conjugation for tumor targeting: a brief review on smancs. J. Protein Chem., 3, 181-193.
21. MAEDA, H., UEDA, M., MORINAGA, T. & MATSUMOTO, T. (1985). Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties. J. Med. Chem., 28, 455-461.
22. MAEDA, H., MATSUMURA, Y. & KATO, H. (1988). Purification and identification of hydroxyprolyP-bradykinin in ascitic fluid from a patients with gastric cancer. J. Biol. Chem., 263, 16051-16054.
23. MAEDA, H. & MATSUMURA, Y. (1989). Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug Carrier Syst., 6, 193-210.
24. MAEDA, H. (1991). SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Delivery Rev., 6, 181-202.
25. MAEDA, H., SEYMOUR, L.W. & MIYAMOTO, Y. (1992). Conjugation of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjugate Chem., 3, 351-362.
26. MATSUMURA, Y. & MAEDA, H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanisms of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 46, 6387-6392.
27. MATSUMURA, Y., KIMURA, M., YAMAMOTO, T. & MAEDA, H. (1988). Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn. J. Cancer Res., 79, 1327-1334.
28. MATSUMURA, Y., KATO, H. & MAEDA, H. (1990). Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC. Agents Actions, 29, 172-180.
29. MATSUMURA, Y., MARUO, K., KIMURA, M., YAMAMOTO, T., KONNO, T. & MAEDA, H. (1991). Kinin-generating cascade in advanced cancer patients and in vitro study. Jpn. J. Cancer Res., 82, 732-741.
30. NOGUCHI, A., TAKAHASHI, T., YAMAGUCHI, T., KITAMURA, K., NOGUCHI, A., TSURUMI, H., TAKASHINA, K. & MAEDA, H. (1992). Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II. Jpn. J. Cancer Res., 83, 240-243.
31. RUSSEL, S.M., KRAUER, K.G., MCKENZIE, F.C. & PIETERSZ, G.A. (1990). Effect of tumor necrosis factor on the antitumor efficacy and toxicity of aminopterine-monoclonal antibody conjugates: parameters for optimization of therapy. Cancer Res., 50, 6028-6033.
32. SATO, H., SATO, K., SATO, Y., ASAMURA, M., KANAMARU, R., SUGIYAMA, Z., KITAHARA, T., WAKUI, A., SUZUKI, M., HORI, K., ABE, I., SAITO, S., & SATO, H. (1981). Induced hypertension chemotherapy of cancer patients by selective enhancement of drug delivery to tumor tissue with angiotensin II. Sci. Rep. Inst. Tohoku Univ. Ser. C 28, 32-44.
33. SENGER, D.R., GALLI, S.J. & DVORAK, A.K. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascitic fluid. Science, 219, 983-985.
34. SKINNER, S.A., TUTTON, P.J.M. & O’BRIEN, P.E. (1990). Microvascular architecture of experimental colon tumors in the rat. Cancer Res., 50, 2411-2417.
35. SMYTH, M.J., PIETERSZ, G.A. & MCKENZIE, F.C. (1987). Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates. J. Natl Cancer Inst., 79, 1367-1373.
36. SUZUKI, M., HORI, K., ABE, I., SAITO, S. & SATO, H. (1981). A new approach to cancer chemotherapy: a selective enhancement of tumor blood flow with angiotensin II. J. Natl Cancer Inst., 67, 663-669.
37. SUZUKI, M., TAKAHASHI, T. & SATO, T. (1987). Medial regression, and its functional significance in tumor-supplying host arteries. Cancer, 59, 444-450.
38. TAKESHITA, J., MAEDA, M. & KANAMARU, R. (1982). In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS. Gann (Jpn. J. Cancer Res.), 73, 278-284.
39. WAKUI, A. & SATO, H. (1984). Clinical studies on induced hypertension chemotherapy based on functional characteristics of microcirculation of tumor vessels. Jpn. J. Cancer Chemother., 11, 741-749 (in Japanese).